We have located links that may give you full text access.
JOURNAL ARTICLE
META-ANALYSIS
SYSTEMATIC REVIEW
The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia 2020 September
OBJECTIVES: We designed this systematic review to estimate pooled prevalence of migraine in patients with multiple sclerosis (MS).
METHODS: We searched PubMed, Scopus, EMBASE, CINAHL, Web of Science, google scholar and gray literature including references from identified studies, conference abstracts which were published up to December 2019. The search strategy included the MeSH and text words as ((Disorder,Migraine OR Disorders,MigraineDisorder OR Migraine OR Migraines, OR MigraineHeadache OR MigraineHeadaches) AND (Multiple Sclerosis OR Sclerosis, Multiple) OR Sclerosis, Disseminated) OR Disseminated Sclerosis) OR MS (Multiple Sclerosis)) OR Multiple Sclerosis, Acute Fulminating).
RESULTS: The literature search found 2100 articles. After eliminating duplicates, 1500 articles remained. Eleven articles and twelve abstract conference papers were included for final analysis. A total of 11,372 MS cases and 2627 MS patients with migraine included in the analysis. The prevalence of migraine ranged from 2% to 67%. The pooled prevalence of migraine in included studies was 31% (95%CI: 22%-40%) (I2 = 99.3%, p < 0.001). The pooled prevalence of migraine in different continents were significantly different (p < 0.001). The pooled prevalence was 24% in Asian countries, 43% in American countries, 25% in European countries and 43% in African countries.
CONCLUSION: The results of this systematic review shows that the prevalence of migraine in MS patients is 31% while the prevalence differs significantly among residents of different continents.
METHODS: We searched PubMed, Scopus, EMBASE, CINAHL, Web of Science, google scholar and gray literature including references from identified studies, conference abstracts which were published up to December 2019. The search strategy included the MeSH and text words as ((Disorder,Migraine OR Disorders,MigraineDisorder OR Migraine OR Migraines, OR MigraineHeadache OR MigraineHeadaches) AND (Multiple Sclerosis OR Sclerosis, Multiple) OR Sclerosis, Disseminated) OR Disseminated Sclerosis) OR MS (Multiple Sclerosis)) OR Multiple Sclerosis, Acute Fulminating).
RESULTS: The literature search found 2100 articles. After eliminating duplicates, 1500 articles remained. Eleven articles and twelve abstract conference papers were included for final analysis. A total of 11,372 MS cases and 2627 MS patients with migraine included in the analysis. The prevalence of migraine ranged from 2% to 67%. The pooled prevalence of migraine in included studies was 31% (95%CI: 22%-40%) (I2 = 99.3%, p < 0.001). The pooled prevalence of migraine in different continents were significantly different (p < 0.001). The pooled prevalence was 24% in Asian countries, 43% in American countries, 25% in European countries and 43% in African countries.
CONCLUSION: The results of this systematic review shows that the prevalence of migraine in MS patients is 31% while the prevalence differs significantly among residents of different continents.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app